|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,351.10 INR | -0.07% |
|
+0.41% | +0.41% |
| 24/12 | Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026 | CI |
| 18/12 | Concord Biotech Names CFO | MT |
| Capitalization | 14TCr 156.44Cr 134.76Cr 125.59Cr 116.83Cr 217.35Cr 233.16Cr 1.44TCr 567.79Cr 6.76TCr 586.62Cr 574.63Cr 25TCr | P/E ratio 2026 * |
40.1x | P/E ratio 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise value | 14TCr 152.2Cr 131.11Cr 122.18Cr 113.67Cr 211.46Cr 226.84Cr 1.4TCr 552.4Cr 6.57TCr 570.73Cr 559.05Cr 24TCr | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 8.7x |
| Free-Float |
24.94% | Yield 2026 * |
0.88% | Yield 2027 * | 1.03% |
Last Transcript: Concord Biotech Limited
| 1 day | -0.07% | ||
| 1 week | +0.41% | ||
| Current month | +0.41% | ||
| 1 month | -0.70% | ||
| 3 months | -10.37% | ||
| 6 months | -26.38% | ||
| Current year | +0.41% |
| 1 week | 1,292.2 |  | 1,365 |
| 1 month | 1,292.2 | | 1,455 |
| Current year | 1,292.2 | | 1,455 |
| 1 year | 1,292.2 | | 2,451.7 |
| 3 years | 900.05 | | 2,664 |
| 5 years | 900.05 | | 2,664 |
| 10 years | 900.05 | | 2,664 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/09/2011 | |
| Chief Executive Officer | 73 | 10/05/2000 | |
Raviraj Karia
DFI | Director of Finance/CFO | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 30/06/2008 | |
| Chairman | 73 | 10/05/2000 | |
| Director/Board Member | 81 | 31/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | +0.41% | -40.03% | - | 156.57Cr | |
| -1.62% | -7.38% | +5.47% | +2.74% | 7.74TCr | |
| +1.97% | +96.50% | +96.50% | +96.50% | 6.09TCr | |
| -0.04% | +2.77% | +36.36% | +225.51% | 5.75TCr | |
| -0.04% | +0.59% | -36.39% | -38.90% | 5.59TCr | |
| -0.44% | -9.37% | +19.55% | -41.48% | 2.48TCr | |
| -0.67% | -0.64% | +45.24% | +30.20% | 2.08TCr | |
| +1.12% | +0.34% | +198.67% | +112.83% | 1.99TCr | |
| +0.75% | -1.67% | +55.02% | +1,234.75% | 1.71TCr | |
| -3.01% | +16.24% | +13.20% | -79.50% | 1.59TCr | |
| Average | -0.24% | -0.06% | +39.36% | +171.41% | 3.52TCr | |
| Weighted average by Cap. | -0.15% | -0.38% | +36.45% | +110.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26TCr 14Cr 12Cr 11Cr 10Cr 19Cr 21Cr 128.95Cr 51Cr 603.88Cr 52Cr 51Cr 2.22TCr | 1.57TCr 17Cr 15Cr 14Cr 13Cr 24Cr 26Cr 159.82Cr 63Cr 748.44Cr 65Cr 64Cr 2.75TCr |
| Net income | 361.66Cr 4Cr 3.45Cr 3.21Cr 2.99Cr 5.56Cr 5.97Cr 37Cr 15Cr 172.9Cr 15Cr 15Cr 634.28Cr | 457.04Cr 5.06Cr 4.36Cr 4.06Cr 3.78Cr 7.03Cr 7.54Cr 47Cr 18Cr 218.49Cr 19Cr 19Cr 801.56Cr |
| Net Debt | -383.09Cr -4.24Cr -3.65Cr -3.4Cr -3.17Cr -5.89Cr -6.32Cr -39Cr -15Cr -183.14Cr -16Cr -16Cr -671.87Cr | -512.96Cr -5.68Cr -4.89Cr -4.56Cr -4.24Cr -7.89Cr -8.46Cr -52Cr -21Cr -245.23Cr -21Cr -21Cr -899.63Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 1,351.10 ₹ | -0.07% | 23,385 |
| 13/26/13 | 1,352.10 ₹ | +1.18% | 52,884 |
| 12/26/12 | 1,336.30 ₹ | +1.22% | 63,652 |
| 09/26/09 | 1,320.20 ₹ | -1.89% | 59,379 |
| 08/26/08 | 1,345.60 ₹ | -1.79% | 71,284 |
Delayed Quote NSE India S.E., January 14, 2026 at 06:10 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CONCORDBIO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition